PDF icon PDF herunterladen
Open Access
CC BY 4.0 · Indian J Med Paediatr Oncol
DOI: 10.1055/s-0042-1756481
Original Article

An Account of Acute Adverse Drug Reactions Occurring in a Day-Care Chemotherapy Unit of a Tertiary Care Cancer Hospital—A Prospective Observational Study

Gonepalli Pravanika Sekhar
1   Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
,
Krishna Mohan Mallavarapu
1   Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
,
Senthil Rajappa
1   Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
,
Santa Ayyagari
1   Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
,
Pavan Kumar Boyela
1   Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
,
Rakesh Pinninti
1   Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
,
Narander Cheraku
1   Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
› Institutsangaben
Funding None.
› Weitere Informationen
Auch verfügbar aufeRef
  Lizenzen und Reprints
Preview

Abstract

Introduction Acute adverse drug reactions (ADRs) in day-care chemotherapy are not uncommon and are easily manageable on most occasions. However, sometimes they may lead to untoward events. It is paramount to document and analyze such events in contemporary medical oncology practice for the best utilization and planning of available personnel and resources.

Objective Our objective was to analyze the acute ADRs occurring in day-care cancer chemotherapy settings.

Materials and Methods ADRs reported in a day-care cancer chemotherapy setting, during the administration of chemotherapy, were prospectively observed and analyzed from 01 June 2020 to 31 December 2020. ADRs were classified into anaphylactic, allergic, and gastrointestinal (GI) (nausea/vomiting/heart burns/chest tightness). All ADRs were graded according to the Common Terminology Criteria for Adverse Events Version 5.0. Suspected drugs, time to reaction, and corrective measures were analyzed.

Results During the study period, a total of 10,120 sessions of day-care chemotherapy were administered. ADRs were noticed in 118 cases (1.18%). Among the reported ADRs, the mean and median age of the patients in this study was 52 years (21–88). Women outnumbered men (n = 81, 68.64% vs n = 37, 31.36%). Anaphylactic reactions (50.92%) were the most common followed by allergic (25.15%) and GI reactions (23.93%). No grade IV reaction was observed. Oxaliplatin-induced allergic reactions (n = 28, 23.73%) were noted most frequently. In majority of sessions (n = 93, 78.81%), the same chemotherapy regimen was readministered and completed uneventfully after the administration of antihypersensitivity medications.

Conclusion Serious ADRs are rare in current day-care chemotherapy administration. Most acute ADRs were of mild grade and successfully managed with antihypersensitivity medication.

Keywords

ADRs - chemotherapy sessions - type of reactions - severity


Publikationsverlauf

Artikel online veröffentlicht:
28. November 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • Reference

  • 1 Common Terminology Criteria for adverse events (CTCAE) version 5.0. U.S Department of Health and Human Services. November 27, 2017:2, 51, 24–43
  • 2 Khandelwal S. et al. Development of a predictor model for quality of life in cancer patients with adverse drug reactions due to cancer chemotherapy. J Appl Pharm Sci 2016; 6 (05) 022-028
    CrossrefSuche in Google Scholar
  • 3 Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992; 49 (09) 2229-2232
    PubMedSuche in Google Scholar
  • 4 Singh S, Dhasmana DC, Bisht M, Singh PK. Patterns of adverse drug reactions to anti-cancer drugs: a quantitative and qualitative analysis. Indian J Med Paediatr Oncol 2017; 38 (02) 140-145
    PubMedSuche in Google Scholar
  • 5 Chopra D, Rehan HS, Sharma V, Mishra R. Chemotherapy-induced adverse drug reactions in oncology patients: a prospective observational survey. Indian J Med Paediatr Oncol 2016; 37 (01) 42-46
    Thieme ConnectPubMedSuche in Google Scholar
  • 6 Poddar S. et al. Pattern of adverse drug reactions due to cancer chemotherapy in tertiary care teaching hospital in Bangladesh. Dhaka Univ J Pharma Sci 2009; 8: 11-16
    CrossrefSuche in Google Scholar
  • 7 Kirthi C. et al. A study on the adverse drug effects of anticancer drug in an oncology center IJPPS Han. 2014; 6: 580-583
    PubMedSuche in Google Scholar
  • 8 Thapaliya K. et al. Study of pattern of adverse drug reactions due to cancer chemotherapy & their management in hospitalized patients in BP Koirala Memorial Cancer Hospital. Journal of Chitwan Medical College 2014;4(10):
  • 9 Aghamohammadi H, Shrestha S, Kavousi S. Assessment of prescribing pattern of chemotherapy drugs and monitoring of adverse drug reaction in cancer patients. IJPSI 2019; 8 (01) 42-51
    Suche in Google Scholar
  • 10 Gunaseelan V. et al. adverse drug reactions to cancer chemotherapy in a regional cancer center in northeast India. IJPSR 2014; 5 (08) 3358-3363
    Suche in Google Scholar
  • 11 Saini VK, Sewal RK, Ahmad Y, Medhi B. Prospective observations study of adverse drug reactions of anti-cancer drugs used in cancer treatment in tertiary care hospital. Indian J Pharm Sci 2015; 77 (06) 687-693
    CrossrefPubMedSuche in Google Scholar
  • 12 Wahlang JB, Laishram PD, Brahma DK, Sarkar C, Lahon J, Nongkynrih BS. Adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital. Ther Adv Drug Saf 2017; 8 (02) 61-66
    CrossrefPubMedSuche in Google Scholar
  • 13 Goyal NY. et al. Pattern of adverse drug reactions due to cancer chemotherapy in tertiary care teaching hospital in Gujarat. Int J Sci Res 2012; 3 (01) 333-335
    Suche in Google Scholar
  • 14 Mallik S, Palaian S, Ojha P, Mishra P. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Nepal. Pak J Pharm Sci 2007; 20 (03) 214-218
    PubMedSuche in Google Scholar
  • 15 Prasad A, Datta PP, Bhattacharya J. et al. Pattern of adverse drug reactions due to cancer chemotherapy in tertiary care teaching hospital in Eastern India. J Pharmacovigil 2013; 1: 107
    Suche in Google Scholar
  • 16 Ramasubbu SK, Pasricha RK, Nath UK, Das B. Frequency, nature, severity and preventability of adverse drug reactions arising from cancer chemotherapy in a teaching hospital. J Family Med Prim Care 2020; 9 (07) 3349-3355
    CrossrefPubMedSuche in Google Scholar
  • 17 Sharma A, Kumari KM, Manohar HD, Bairy KL, Thomas J. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India. Perspect Clin Res 2015; 6 (02) 109-115
    CrossrefPubMedSuche in Google Scholar